Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Primary relevance to vitamin D Vitamin D is a stated subject of this paper.

Vitamin D is a stated subject of this paper; the supporting source evidence is shown below.

Why this paper is included

Supporting source evidence:

This study aimed to determine vitamin D status in children with COVID-19 and assess its impact on the clinical course of disease and long COVID development.

Source: Abstract. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Cohort study.

Cohort study

Examines exposures and outcomes over time within a defined group.

Meta-analysis unclear · Blinding unclear / not reported · Human research reported

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

A prospective cohort study was conducted from September 2022 to March 2024 in the pediatric infectious diseases department of a tertiary-level hospital in Ternopil, Ukraine.

Source: Methods.

The study included hospitalized patients aged 1 month to 18 years diagnosed with COVID-19.

Source: Methods.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

Vitamin D status in children with COVID-19: does it affect the development of long COVID and its symptoms?

Cohort study · Frontiers in Pediatrics · 2025

Original publication title

Vitamin D status in children with COVID-19: does it affect the development of long COVID and its symptoms?

Vita Perestiuk; Tetyana Kosovska; Olha Dyvoniak; Liubov Volianska; Oksana Boyarchuk

© 2025 Perestiuk, Kosovska, Dyvoniak, Volianska and Boyarchuk.

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

Authors’ conclusion

The 25(OH)D concentrations in children with COVID-19 depended on their age. Comorbid conditions affect the vitamin D status in children with COVID-19. Vitamin D influenced the COVID-19 severity and duration of hospitalization. There was an increased risk of developing long COVID in children with vitamin D deficiency/insufficiency, and its impact on the development of neurological symptoms associated with long COVID was established.

An extract from the source publication. Read it in context.

At a glance

Abstract: What background does the paper provide?

Long COVID is characterized by diverse symptoms persisting after severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Given the immunomodulatory and neuroprotective properties of vitamin D, understanding its role in long COVID symptoms is of growing interest. This study aimed to determine vitamin D status in children with COVID-19 and assess its impact on the clinical course of disease and long COVID development.

Source: Introduction

Abstract: What methods does the paper describe?

A prospective cohort study included hospitalized children with confirmed COVID-19, aged 1 month to 18 years, diagnosed between September 2022 and March 2024. Serum 25-hydroxyvitamin D (25(OH)D) concentrations were measured upon hospital admission, and follow-up was done to identify long COVID symptoms.

Source: Methods

Abstract: Results

In total, 162 hospitalized patients with COVID-19 were examined. Vitamin D deficiency was determined in 8.0%, insufficiency in 25.3%, and optimal levels in 66.7% of children with COVID-19. Vitamin D deficiency/insufficiency was observed in 73% of children over 6 years and 21.6% of children under 6 years of age. Comorbid conditions were 1.4 times more frequent in children with vitamin D insufficiency, with undernutrition and obesity playing the most significant roles (p = 0.0023, p = 0.0245, respectively). Serum 25(OH)D concentration depends on COVID-19 severity (p = 0.0405) and children with vitamin D deficiency/insufficiency had a longer hospital stay (4 vs. 3 days, p = 0.0197).

The vitamin D status affected the median levels of neutrophils, lymphocytes, their ratio, prothrombin time, fibrinogen levels, and the frequency of increased immunoglobulins M and E levels. Among 134 children who agreed to follow up, 56 (41.8%) experienced long COVID symptoms, while 78 (58.2%) recovered fully. Long COVID was frequently observed in children with vitamin D deficiency/insufficiency (p = 0.0331). The odds of developing long COVID were 2.2 times higher (p = 0.0346) in children with vitamin D deficiency/insufficiency compared to those with optimal levels.

Children with vitamin D deficiency/insufficiency more often exhibited neurological (80% vs. 41.9%, p = 0.0040) and musculoskeletal symptoms (16% vs. 0%, p = 0.0208).

Source: Results

Abstract: Conclusion

The 25(OH)D concentrations in children with COVID-19 depended on their age. Comorbid conditions affect the vitamin D status in children with COVID-19. Vitamin D influenced the COVID-19 severity and duration of hospitalization. There was an increased risk of developing long COVID in children with vitamin D deficiency/insufficiency, and its impact on the development of neurological symptoms associated with long COVID was established.

Source: Conclusion
Authors’ abstract

Introduction

Long COVID is characterized by diverse symptoms persisting after severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Given the immunomodulatory and neuroprotective properties of vitamin D, understanding its role in long COVID symptoms is of growing interest. This study aimed to determine vitamin D status in children with COVID-19 and assess its impact on the clinical course of disease and long COVID development.

Methods

A prospective cohort study included hospitalized children with confirmed COVID-19, aged 1 month to 18 years, diagnosed between September 2022 and March 2024. Serum 25-hydroxyvitamin D (25(OH)D) concentrations were measured upon hospital admission, and follow-up was done to identify long COVID symptoms.

Results

In total, 162 hospitalized patients with COVID-19 were examined. Vitamin D deficiency was determined in 8.0%, insufficiency in 25.3%, and optimal levels in 66.7% of children with COVID-19. Vitamin D deficiency/insufficiency was observed in 73% of children over 6 years and 21.6% of children under 6 years of age. Comorbid conditions were 1.4 times more frequent in children with vitamin D insufficiency, with undernutrition and obesity playing the most significant roles (p = 0.0023, p = 0.0245, respectively). Serum 25(OH)D concentration depends on COVID-19 severity (p = 0.0405) and children with vitamin D deficiency/insufficiency had a longer hospital stay (4 vs. 3 days, p = 0.0197).

The vitamin D status affected the median levels of neutrophils, lymphocytes, their ratio, prothrombin time, fibrinogen levels, and the frequency of increased immunoglobulins M and E levels. Among 134 children who agreed to follow up, 56 (41.8%) experienced long COVID symptoms, while 78 (58.2%) recovered fully. Long COVID was frequently observed in children with vitamin D deficiency/insufficiency (p = 0.0331). The odds of developing long COVID were 2.2 times higher (p = 0.0346) in children with vitamin D deficiency/insufficiency compared to those with optimal levels.

Children with vitamin D deficiency/insufficiency more often exhibited neurological (80% vs. 41.9%, p = 0.0040) and musculoskeletal symptoms (16% vs. 0%, p = 0.0208).

Conclusion

The 25(OH)D concentrations in children with COVID-19 depended on their age. Comorbid conditions affect the vitamin D status in children with COVID-19. Vitamin D influenced the COVID-19 severity and duration of hospitalization. There was an increased risk of developing long COVID in children with vitamin D deficiency/insufficiency, and its impact on the development of neurological symptoms associated with long COVID was established.

Publication and source details

Original title: Vitamin D status in children with COVID-19: does it affect the development of long COVID and its symptoms?

Vita Perestiuk; Tetyana Kosovska; Olha Dyvoniak; Liubov Volianska; Oksana Boyarchuk

Frontiers in Pediatrics · 2025

Edited by: Mourad Aribi, University of Abou Bekr Belkaïd, Algeria

Reviewed by: Israel Parra-Ortega, Federico Gómez Children’s Hospital, Mexico

Jessie Zurita-Cruz, Hospital Infantil de México Federico Gómez, Mexico

* Correspondence: Vita Perestiuk perestiuk_vo@tdmu.edu.ua
© 2025 Perestiuk, Kosovska, Dyvoniak, Volianska and Boyarchuk.2025Perestiuk, Kosovska, Dyvoniak, Volianska and Boyarchukhttps://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.Ministry of Health of Ukraine0123U100301The author(s) declare financial support was received for the research, authorship, and/or publication of this article. The study was financed by the Ministry of Health of Ukraine with funds from the state budget, project title “Assessment of the quality of life and psychological state of children with long COVID-19 in time of war”, state registration number 0123U100301, implementation period: 2023 to 2025.

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-11T02:45:11.291911+00:00

DOI: 10.3389/fped.2025.1507169 · PMC11881026